Table 1 Clinicopathologic features of the patients
Patient number | |
|---|---|
Total patients | 40 |
Age, median (range) | 49 (36–68) |
ECOG performance: | |
0 | 10 (25.0%) |
1 | 24 (60.0%) |
2 | 6 (15.0%) |
Menopausal status | |
Premenopause | 18 (45.0%) |
Postmenopause | 22 (55.0%) |
Oestrogen receptor status | |
Positive | 21 (52.5%) |
Negative | 11 (27.5%) |
Unknown | 8 (20.0%) |
Disease status | |
Recurrence/metastasis | 25 (62.5%) |
de novo metastasis | 15 (37.5%) |
Prior therapy | |
Anthracycline-containing adjuvant chemotherapy | 15 (37.5%) |
CMF adjuvant chemotherapy | 2 (5.0%) |
Hormonal therapy | 21 (52.5%) |
Local radiotherapy | 11 (27.5%) |
Disease sites | |
Lymph nodes | 33 (82.5%) |
Lung | 26 (65.0%) |
Breast | 19 (47.5%) |
Bone or/and spine | 16 (40.0%) |
Liver | 12 (30.0%) |
Pleural effusion | 8 (20.0%) |
Skin | 6 (15.0%) |
Others | 1 (2.5%) |
